Inventor · disambiguated record
Marc E. Lippman
Also filed as: LIPPMAN MARC · LIPPMAN MARC E
11 granted patents·6 pending applications·292 citations·filing 1993–2022
91Inventor score
Files withUNIV GEORGETOWN6MARS INC5Geneyus LLC1HUMAN GENOME SCIENCES INC1UNIV GEORGETOWN MED CENTER1
Top patents by PatentIndex Score
17 records- 0192US5578482ALigand growth factors that bind to the erbB-2 receptor protein and induce cellular responsesUNIV GEORGETOWN·Filed 1993·Granted Nov 26, 1996·103 cites·5 claims
- 0290US5869618AAntibodies to ligand growth factorsFiled 1995·Granted Feb 9, 1999·111 cites·6 claims
- 0388US6528664B2Synthetic methods for polyphenolsMARS INC·Filed 2001·Granted Mar 4, 2003·15 cites·18 claims
- 0480US6420572B1Synthetic methods for preparation of protected proanthocyanidin(s)MARS INC·Filed 1998·Granted Jul 16, 2002·31 cites·16 claims
- 0579US6849746B2Synthetic methods for polyphenolsMARS INC·Filed 2003·Granted Feb 1, 2005·5 cites·22 claims
- 0666US7268240B2Synthetic methods for polyphenolsMARS INC·Filed 2004·Granted Sep 11, 2007·1 cites·14 claims
- 0756US2004235941A1Dimer digallate compositionsMARS INC·Filed 2004·Application pending·0 cites
- 0855US2024226065A1Use of rage inhibitors to treat cancer-related cognitive declineUNIV GEORGETOWN·Filed 2022·Application pending·0 cites
- 0951US2005214305A1VEGI, an inhibitor of angiogenesis and tumor growthUNIV GEORGETOWN MED CENTER·Filed 2004·Application pending·0 cites
- 1050US5874528ABinding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptorUNIV GEORGETOWN·Filed 1993·Granted Feb 23, 1999·15 cites·2 claims
- 1145US2002111325A1VEGI, an inhibitor of angiogenesis and tumor growthHUMAN GENOME SCIENCES INC·Filed 2001·Application pending·0 cites
- 1241US6143740AHeregulin antagonists and methods for their useUNIV GEORGETOWN·Filed 1997·Granted Nov 7, 2000·6 cites·10 claims
- 1337US6040290ALigand growth factor gp30 that binds to the erbB-2 receptor protein and induces cellular responsesUNIV GEORGETOWN·Filed 1996·Granted Mar 21, 2000·5 cites·7 claims
- 1437US2006166920A1Oligonucleotide based therapeuticsUNIV MICHIGAN·Filed 2005·Application pending·0 cites
- 1536US10472352B2Rac inhibitorsGeneyus LLC·Filed 2018·Granted Nov 12, 2019·0 cites·18 claims
- 1635US2011123441A1Novel greb1a monoclonal antibodyUNIV MIAMI·Filed 2010·Application pending·0 cites
- 1721US6566104B1ERbB-4 targeted ribozymesUNIV GEORGETOWN·Filed 1998·Granted May 20, 2003·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Marc E. Lippman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →